Although PYY does not exert a direct insulinotropic effect—a critical difference compared to GLP-1—its multifaceted actions on satiety, alimentary behavior, and glucose regulation underscore its potential for addressing both overeating and hyperglycemia in T2D patients [1]. The gene discussed is PYY; the disease is type 2 diabetes mellitus.